TokenPost·
Biohaven Shares Rise About 25% After FDA Accepts Resubmission
25%
share price gain
The agency set a first-quarter 2027 user-fee goal date and plans to convene an advisory committee, with no meeting date announced.
More news
- TokenPostUkrainian Strikes Shut Two Yandex Data Centers and Hit Part of a Third
- CryptoSlateNEAR proposal slashes yield by 36%, dividing network validators
- TokenPostGoogle Expects to Invest $1 Billion in U.S. Data-Center Communities
- TokenPostU.S. Natural Gas Storage Adds 77 Bcf, Reaching 3,644 Bcf
- TokenPostTruckers' Strike Over Diesel Prices Halts Southern Italy's Mozzarella Production
- Crypto BriefingInDrive plans 2027 robotaxi tests in Kazakhstan with Pony.ai and Nvidia